Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D in Childhood Growth, Bone and Muscle: Study Summary

Previous related pageVitamin D in Childhood Growth, Bone and Muscle: Full Evidence ReviewNext related pageVitamin D in Childhood Growth, Bone and Muscle: Full Evidence Review
Study at a glance

What was studied?

Do vitamin D supplements improve growth, bone or muscle outcomes in children?

What did the studies find?

Four separate trials changed vitamin D blood status without consistently demonstrating better height, strength or measured bone outcomes. One trial also lowered a calcium-regulating hormone without an overall added bone-mineral benefit. A partly accessible bone report described mixed findings.

What does this mean?

A change in a blood test or hormone does not automatically mean that a child grows more or becomes stronger. The result depends on the children, the intervention and the outcome measured.

What are the limits?

Some bone evidence could not be assessed fully, including the D-pro bone paper and a Mongolian fracture report. The review does not show that all bone studies agree or that treating clinical deficiency is unnecessary. Research schedules are not personal supplement advice.

Read the full article below ↓

Vitamin D supplements can change a child’s blood result without making the child taller or stronger. This summary compares four childhood trials that measured vitamin D status, growth, bone or muscle outcomes. Some important bone evidence could be inspected only partly. The findings therefore do not support a claim that every bone study agrees. For the detailed evidence review, read Vitamin D in Childhood Growth, Bone and Muscle: Full Evidence Review.

For current UK guidance, including advice for children, see the NHS page Vitamin D.

Different measurements answer different questions

The usual blood test measures 25-hydroxyvitamin D, shortened to 25(OH)D. This indicates vitamin D status. It is not the same substance as the active vitamin D hormone, and it does not directly measure bone strength or muscle development. Vitamin D and Bone introduces the wider bone physiology.

The studies measured several outcomes. Height describes growth in length. Bone scans estimate mineral content or density. Grip and leg tests measure particular aspects of strength. A change in one measurement does not guarantee a change in the others. These differences are explained in Bone Mineralisation, Turnover and Fractures Measure Different Outcomes.

Some studies also measured parathyroid hormone, called PTH. This hormone helps regulate calcium. A lower PTH result can show a physiological response, but it does not by itself prove that bones gained more mineral.

What happened in the larger trials?

A Mongolian trial included 8,851 children aged six to 13. Most began with low vitamin D status. Children received vitamin D or placebo for three years. The supplement raised blood status substantially, but the study did not find an overall advantage in measured muscle strength or exercise outcomes.

For grip strength, the estimated difference was only 0.01 kg. The uncertainty interval ranged from −0.21 to 0.23 kg. This does not support a claim that supplementation made the group stronger on this test. It also does not answer every question about muscle health. Children with rickets were excluded, and some exercise tests involved smaller groups.

The South African ViDiKids trial included 1,682 children aged six to 11. In its bone substudy, low starting status was relatively uncommon. After three years, supplementation increased vitamin D status and lowered PTH. However, the trial did not demonstrate an overall increase in the bone mineral content measured by scans.

A report from the same trial also found no demonstrated improvement in height growth. These are two reports about one trial population, not two independent experiments. There were too few fractures to draw a precise conclusion about fracture prevention.

What did the smaller trials add?

The Danish D-pro trial studied 200 healthy children aged six to eight over 24 winter weeks. It compared vitamin D with placebo and also compared two yogurt protein levels. Starting vitamin D status was generally adequate. Supplementation helped maintain winter status but did not establish an overall improvement in strength or physical performance.

A suggested difference between boys and girls did not prove that vitamin D improved girls’ strength. The relevant comparison is between girls receiving vitamin D and girls receiving placebo, not simply between boys and girls receiving the supplement.

The D-pro bone report described a null main bone-density result alongside positive results for some secondary bone measurements. We could inspect only part of that report, not its complete methods and supporting analyses. This limits our assessment of the bone evidence. Those mixed findings must not be omitted to create a claim that all bone trials were negative.

A Northern Irish trial assigned 118 children aged four to 11 to vitamin D spray or placebo for 12 weeks. Vitamin D status increased, but exploratory muscle and bone-related laboratory outcomes did not establish an additional benefit. The trial was short and mainly designed to assess blood status. Missing data and the inclusion of siblings further limit how firmly its developmental outcomes can be interpreted.

What do these results mean?

The clearest shared finding is that a higher vitamin D blood result does not automatically mean greater height, strength or bone mineral. The South African trial also showed that a hormone can respond without a corresponding overall bone-mineral advantage.

This does not establish that vitamin D is unimportant or that treating clinical deficiency is unnecessary. The trials studied particular children, schedules and outcomes. Some excluded children with conditions such as rickets. Their conclusions should not be extended to those excluded groups. Vitamin D and Muscle Function provides background on the muscle question; these trials test particular outcomes within it.

The bone assessment remains incomplete. The D-pro bone paper was only partly accessible, and a separate Mongolian fracture report was not fully assessed. This review therefore makes no detailed fracture claim from that Mongolian paper and no claim that all skeletal evidence agrees.

The experimental schedules are research protocols, not instructions for a child’s supplements. These studies do not identify one blood target or treatment plan suitable for every child. Their value is in separating what changed in the trials from what remains uncertain.

Scientific sources

Not reportedInfluence of vitamin D supplementation on muscle strength and exercise capacity in Mongolian schoolchildren: secondary outcomes from a randomised controlled trial. Ganmaa D et al. BMJ Open Sport & Exercise Medicine. 2024;10:e002018. DOI:10.1136/bmjsem-2024-002018.

Not reportedInfluence of vitamin D supplementation on bone mineral content, bone turnover markers, and fracture risk in South African schoolchildren: multicenter double-blind randomized placebo-controlled trial (ViDiKids). Middelkoop K et al. Journal of Bone and Mineral Research. 2024;39:211 to 221. DOI:10.1093/jbmr/zjae007.

Not reportedInfluence of vitamin D supplementation on growth, body composition, pubertal development and spirometry in South African schoolchildren: a randomised controlled trial (ViDiKids). Middelkoop K et al. BMJ Paediatrics Open. 2024. DOI:10.1136/bmjpo-2024-002495.

Not reportedVitamin D supplementation and increased dairy protein intake do not affect muscle strength or physical function in healthy 6 to 8-year-old children: the D-pro randomized trial. Thams L et al. European Journal of Nutrition. 2022;61:3613 to 3623. DOI:10.1007/s00394-022-02912-0.

Not reportedThe Effect of Vitamin D3 Supplementation on Vitamin D Status and Associated Health Outcomes in Children: A Randomized Controlled Trial. Royle E et al. Journal of Nutrition. 2026;156:101493. DOI:10.1016/j.tjnut.2026.101493.

Not reportedEffects of vitamin D and high dairy protein intake on bone mineralization and linear growth in 6: to 8-year-old children: the D-pro randomized trial. Stounbjerg NG et al. American Journal of Clinical Nutrition. 2021;114:1971 to 1985. DOI:10.1093/ajcn/nqab286. Abstract and indexed sections only; complete principal paper and material supplement not assessed.

Not reportedVitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Diabetes & Endocrinology. 2024;12:29 to 38. DOI:10.1016/S2213-8587(23)00317-0. Identified companion report; complete principal paper not assessed and detailed fracture conclusions not drawn here.

Related reading

Physiology

Vitamin D and Bone

Learn how vitamin D supports bone through calcium and phosphate regulation, tissue repair, muscle: bone interaction, kidney signalling, and long-term skeletal resilience.

Read more →

Original sources

Source

Vitamin D

For current UK guidance, including advice for children, see the NHS page Vitamin D.

Publication details

For current UK guidance, including advice for children, see the NHS page Vitamin D.

Read more →
Source

Influence of vitamin D supplementation on muscle strength and exercise capacity in Mongolian schoolchildren: secondary outcomes from a randomised controlled trial

Multicentre, randomised, placebo-controlled clinical trial conducted in children aged 6 to 13 years at baseline attending 18 schools in Ulaanbaatar.

Publication details

Not reportedInfluence of vitamin D supplementation on muscle strength and exercise capacity in Mongolian schoolchildren: secondary outcomes from a randomised controlled trial. Ganmaa D et al. BMJ Open Sport & Exercise Medicine. 2024;10:e002018. DOI:10.1136/bmjsem-2024-002018.

Read more →
Source

Influence of vitamin D supplementation on bone mineral content, bone turnover markers, and fracture risk in South African schoolchildren: multicenter double-blind randomized placebo-controlled trial (ViDiKids)

Randomized controlled trials (RCTs) to determine the influence of vitamin D on BMC and fracture risk in children of Black African ancestry are lacking.

Publication details

Not reportedInfluence of vitamin D supplementation on bone mineral content, bone turnover markers, and fracture risk in South African schoolchildren: multicenter double-blind randomized placebo-controlled trial (ViDiKids). Middelkoop K et al. Journal of Bone and Mineral Research. 2024;39:211 to 221. DOI:10.1093/jbmr/zjae007.

Read more →
Source

Influence of vitamin D supplementation on growth, body composition, pubertal development and spirometry in South African schoolchildren: a randomised controlled trial (ViDiKids)

A second potential limitation relates to the fact that pubertal status was assessed by participants themselves, rather than by health professionals, whose judgement may be more objective.

Publication details

Not reportedInfluence of vitamin D supplementation on growth, body composition, pubertal development and spirometry in South African schoolchildren: a randomised controlled trial (ViDiKids). Middelkoop K et al. BMJ Paediatrics Open. 2024. DOI:10.1136/bmjpo-2024-002495.

Read more →
Source

Vitamin D supplementation and increased dairy protein intake do not affect muscle strength or physical function in healthy 6–8-year-old children: the D-pro randomized trial

Published in Thams L et al. European Journal of Nutrition (2022).

Publication details

Not reportedVitamin D supplementation and increased dairy protein intake do not affect muscle strength or physical function in healthy 6 to 8-year-old children: the D-pro randomized trial. Thams L et al. European Journal of Nutrition. 2022;61:3613 to 3623. DOI:10.1007/s00394-022-02912-0.

Read more →
Source

Effects of vitamin D and high dairy protein intake on bone mineralization and linear growth in 6- to 8-year-old children: the D-pro randomized trial

Published in Stounbjerg NG et al. American Journal of Clinical Nutrition (2021).

Publication details

Not reportedEffects of vitamin D and high dairy protein intake on bone mineralization and linear growth in 6: to 8-year-old children: the D-pro randomized trial. Stounbjerg NG et al. American Journal of Clinical Nutrition. 2021;114:1971 to 1985. DOI:10.1093/ajcn/nqab286. Abstract and indexed sections only; complete principal paper and material supplement not assessed.

Read more →
Source

Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trial

Published in Lancet Diabetes & Endocrinology (2024).

Publication details

Not reportedVitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Diabetes & Endocrinology. 2024;12:29 to 38. DOI:10.1016/S2213-8587(23)00317-0. Identified companion report; complete principal paper not assessed and detailed fracture conclusions not drawn here.

Read more →